Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeverfield Regulatory News (SFR)

Share Price Information for Severfield (SFR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 69.60
Bid: 66.20
Ask: 69.40
Change: 1.80 (2.65%)
Spread: 3.20 (4.834%)
Open: 66.00
High: 69.60
Low: 66.00
Prev. Close: 67.80
SFR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

6 Sep 2017 13:07

RNS Number : 9992P
Severfield PLC
06 September 2017
 

SEVERFIELD PLC

Results of Annual General Meeting 2017

At the Company's Annual General Meeting held at 12 noon today, 6 September, all of the resolutions were passed on a show of hands.

Copies of all the resolutions passed have been submitted to the UK Listing Authority via the National Storage Mechanism and will shortly be available for review at http://www.hemscott.com/nsm.do.

A summary of Proxies received in respect of each resolution is set out below (a "vote withheld" is not a vote in law and is not counted in the calculation of the proportion of the votes for and against the resolution):

In Favour

Against

Total

Withheld

Resolution

No of votes

% of votes

No of votes

% of votes

No of votes

No of votes

1. To receive and adopt the annual accounts and the reports of the Directors for the financial year ended 31 March 2017 together with the report of the auditor thereon.

230,966,066

100.00

7,906

0.00

230,973,972

1,572,906

2. To approve the Directors' remuneration report (other than the part containing the directors' remuneration policy) for the financial year ended 31 March 2017 as set out in the Annual Report and Accounts 2017.

232,317,280

99.96

91,930

0.04

232,409,210

137,668

3. To approve the Directors' remuneration policy, the full text of which is set out on pages 83 to 90 of the Annual Report and Accounts 2017.

231,684,761

99.66

801,189

0.34

232,485,950

60,928

4. To declare a final dividend of 1.6p per ordinary share in respect of the year ended 31 March 2017 payable on 15th September 2017 to shareholders on the register at the close of business on 18th August 2017.

232,546,878

100.00

0

0.00

232,546,878

0

5. To reappoint John Dodds as a Director.

227,963,446

98.03

4,571,981

1.97

232,535,427

11,451

6. To reappoint Ian Lawson as a Director.

229,145,681

98.54

3,389,746

1.46

232,535,427

11,451

7. To reappoint Ian Cochrane as a Director.

229,153,889

98.55

3,381,538

1.45

232,535,427

11,451

8. To reappoint Alan Dunsmore as a Director.

229,126,464

98.53

3,408,963

1.47

232,535,427

11,451

9. To reappoint Derek Randall as a Director.

229,157,347

98.55

3,378,080

1.45

232,535,427

11,451

10. To reappoint Alun Griffiths as a Director.

228,314,389

98.18

4,221,038

1.82

232,535,427

11,451

11. To reappoint Chris Holt as a Director.

228,323,546

98.19

4,201,215

1.81

232,524,761

22,117

12. To reappoint Tony Osbaldiston as a Director.

228,319,456

98.19

4,205,305

1.81

232,524,761

22,117

13. To reappoint Kevin Whiteman as a Director.

228,350,106

98.20

4,174,655

1.80

232,524,761

22,117

14. To reappoint KPMG LLP as auditor of the Company to hold office until the conclusion of the next Annual General Meeting of the Company in 2017.

232,492,471

99.98

38,356

0.02

232,530,827

16,051

15. To authorise the Directors to determine the auditor's remuneration.

232,499,004

99.99

19,648

0.01

232,518,652

28,226

16. To authorise the Directors to allot securities of the Company.

232,301,597

99.95

117,055

0.05

232,418,652

128,226

17. To authorise the Directors to dis-apply pre-emption rights in relation to the issue of securities of the Company.

232,288,363

99.95

111,789

0.05

232,400,152

146,726

18. To authorise the Directors to dis-apply pre-emption rights in connection with an acquisition or other capital investment.

231,606,511

99.66

793,641

0.34

232,400,152

146,726

19. To authorise the Company to make market purchases of the Company's ordinary shares.

231,570,101

99.59

953,929

0.41

232,524,030

22,848

20. That a general meeting of the Company (other than an annual general meeting) may be called on not less than 14 clear days' notice.

229,432,915

98.67

3,095,463

1.33

232,528,378

18,500

21. Amendment of the rules of the 2017 performance share plan

231,652,197

99.66

787,527

0.34

232,439,724

107,154

22. Increase fees for directors

231,521,220

99.89

263,171

0.11

231,784,391

762,487

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGGMGGLZVDGNZM
Date   Source Headline
3rd Oct 20227:00 amRNSDirectorate Change
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
21st Sep 20224:35 pmRNSPrice Monitoring Extension
8th Sep 202211:44 amRNSResult of AGM
8th Sep 20227:31 amRNSProgressive publishes new research
8th Sep 20227:00 amRNSTrading Statement
8th Aug 202212:00 pmRNSNotice of Annual General Meeting and Annual Report
27th Jul 20222:31 pmRNSHolding(s) in Company
25th Jul 20229:40 amRNSDirector/PDMR Shareholding
13th Jul 202211:26 amRNSDirector/PDMR Shareholding
29th Jun 202212:01 pmRNSDirector/PDMR Shareholding
29th Jun 202212:00 pmRNSDirector/PDMR Shareholding
17th Jun 202210:36 amRNSDirector/PDMR Shareholding
15th Jun 20227:29 amRNSProgressive publishes new research
15th Jun 20227:00 amRNSResults for the year ended 26 March 2022
1st Jun 20229:47 amRNSTotal Voting Rights and Share Capital Update
3rd May 20221:12 pmRNSVoting Rights and Share Capital Update
25th Apr 20225:24 pmRNSHolding(s) in Company
20th Apr 20229:38 amRNSProgressive publishes new research
20th Apr 20227:00 amRNSPre-close Trading Update
5th Apr 20224:22 pmRNSHolding(s) in Company
1st Apr 20222:23 pmRNSVoting Rights and Share Capital Update
18th Mar 20224:35 pmRNSPrice Monitoring Extension
17th Mar 20227:00 amRNSAppointment of Joint Broker
10th Mar 20221:59 pmRNSReplacement - Holding(s) in Company
10th Mar 20227:35 amRNSNotice of Change to Director Details
7th Mar 20226:12 pmRNSHolding(s) in Company
2nd Mar 20224:43 pmRNSVoting Rights and Share Capital Update
2nd Mar 20224:40 pmRNSDirector/PDMR Shareholding
2nd Feb 20229:16 amRNSVoting Rights and Share Capital Update
5th Jan 202211:31 amRNSVoting Rights and Share Capital Update
20th Dec 20214:31 pmRNSCompletion of successful refinancing
9th Dec 20217:59 amRNSNotice of Change to Director Details
7th Dec 20213:31 pmRNSDirector/PDMR Shareholding
23rd Nov 20212:17 pmRNSIssue of Ordinary Shares
23rd Nov 20217:57 amRNSProgressive publishes new research
23rd Nov 20217:01 amRNSInterim Dividend Declaration
23rd Nov 20217:00 amRNSInterim Results
9th Nov 202112:53 pmRNSIssue of Ordinary Shares
29th Oct 202112:55 pmRNSIssue of Ordinary Shares
19th Oct 20212:30 pmRNSDirector/PDMR Shareholding
13th Oct 20214:35 pmRNSPrice Monitoring Extension
13th Oct 202111:30 amRNSDirector/PDMR Shareholding - AMENDED
12th Oct 20215:43 pmRNSDirector/PDMR Shareholding
12th Oct 202110:45 amRNSIssue of Ordinary Shares
5th Oct 202112:47 pmRNSDirector/PDMR Shareholding
4th Oct 20214:08 pmRNSDirector/PDMR Shareholding
29th Sep 202112:39 pmRNSIssue of Ordinary Shares
28th Sep 20215:56 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.